What is Inversion Therapeutics worth?
$17.0Mlast known valuation
Inversion Therapeutics last raised $6.9M in its Early Stage VC (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Inversion Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Early Stage VC | $6.9M | ▮ | ▮ |
How Inversion Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Inversion Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Inversion Therapeutics worth?
- Inversion Therapeutics's last known valuation is $17.0M.
- How much has Inversion Therapeutics raised?
- Inversion Therapeutics has raised $6.9M in total funding across 1 recorded rounds.
- When did Inversion Therapeutics last raise?
- Inversion Therapeutics last raised in Jun 2025 (Early Stage VC), raising $6.9M.